These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 18217188

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by activating Akt signaling.
    Chen LM, Xiong YS, Kong FL, Qu M, Wang Q, Chen XQ, Wang JZ, Zhu LQ.
    J Neurochem; 2012 Jan; 120(1):157-64. PubMed ID: 21496024
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
    Selenica ML, Jensen HS, Larsen AK, Pedersen ML, Helboe L, Leist M, Lotharius J.
    Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
    Zhang YJ, Xu YF, Liu YH, Yin J, Wang JZ.
    FEBS Lett; 2005 Nov 07; 579(27):6230-6. PubMed ID: 16253246
    [Abstract] [Full Text] [Related]

  • 31. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 07; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 32. Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways.
    Wang Y, Liu W, He X, Zhou F.
    J Mol Neurosci; 2013 Nov 07; 51(3):911-8. PubMed ID: 23979838
    [Abstract] [Full Text] [Related]

  • 33. Selective loss of basal forebrain cholinergic neurons by 192 IgG-saporin is associated with decreased phosphorylation of Ser glycogen synthase kinase-3beta.
    Hawkes C, Jhamandas JH, Kar S.
    J Neurochem; 2005 Oct 07; 95(1):263-72. PubMed ID: 16181430
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Exploring allocryptopine as a neuroprotective agent against oxidative stress-induced neural apoptosis via Akt/GSK-3β/tau pathway modulation.
    Aslim B, Nigdelioglu Dolanbay S, Baran SS.
    Comput Biol Chem; 2024 Oct 07; 112():108144. PubMed ID: 39004026
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX.
    J Alzheimers Dis; 2013 Oct 07; 33(2):329-38. PubMed ID: 22936005
    [Abstract] [Full Text] [Related]

  • 39. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
    Cedazo-Mínguez A, Popescu BO, Blanco-Millán JM, Akterin S, Pei JJ, Winblad B, Cowburn RF.
    J Neurochem; 2003 Dec 07; 87(5):1152-64. PubMed ID: 14622095
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.